Description
Tesamorelin Research Peptide
Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone, commonly abbreviated as GHRH. Published research has examined tesamorelin in relation to pituitary signaling and the growth hormone and insulin-like growth factor 1, or GH/IGF-1, axis.
East Coast Peptides offers tesamorelin in a 10 mg research format supported by lot-specific analytical documentation. This material is supplied exclusively for controlled laboratory investigation and is not intended for human or veterinary use.
Tesamorelin and GHRH Research
Naturally occurring GHRH is involved in signaling between the hypothalamus and anterior pituitary gland. Through interaction with GHRH receptors on pituitary somatotroph cells, it participates in the regulation of pulsatile growth hormone release. Growth hormone can subsequently influence downstream IGF-1 signaling and other endocrine pathways.
Published tesamorelin research has evaluated endpoints including growth hormone pulsatility, IGF-1 concentrations, adipose-tissue measurements, lipid markers and glucose-related variables. Some studies used randomized, placebo-controlled clinical designs involving adults with HIV-associated central fat accumulation. Other work has investigated the relationship between changes in visceral adipose tissue and liver-fat measurements within similarly defined populations.
These clinical findings require careful interpretation. They concern regulated pharmaceutical tesamorelin formulations used under controlled medical-study conditions in specific patient populations. They do not establish general weight-loss, muscle-building, performance, anti-aging or body-composition outcomes, and they should not be attributed to the East Coast Peptides research product.
The ECP product is laboratory research material and is not the branded prescription medication. Researchers should verify the identity and specifications of the current lot and use independently validated analytical or experimental methods appropriate to their research question.
Selected Research References
- Effects of a Growth Hormone-Releasing Hormone Analog on Endogenous GH Pulsatility and Insulin Sensitivity
- Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV
- Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients
Product Information
- Product: Tesamorelin research peptide
- Compound type: Synthetic GHRH analog
- Length: 44 amino acids
- Format: 10 mg
- Documentation: Lot-specific analytical results are available through the ECP COA Catalog.
- Intended application: Laboratory research only
Continue Your Research
Explore evidence-aware compound overviews, comparisons, and laboratory research topics in the ECP Research Blog.
Research Use Notice
This product is sold exclusively for laboratory and research use. Not for human or animal use. It is not intended to diagnose, treat, cure, or prevent any disease. No medical or therapeutic claims are made or implied.











Reviews
There are no reviews yet.